US Patent Issued to Tempus AI on Sept. 8 for "Systems and methods for automating RNA expression calls in a cancer prediction pipeline" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,731,659, issued on Sept. 8, was assigned to Tempus AI Inc. (Chicago).

"Systems and methods for automating RNA expression calls in a cancer prediction pipeline" was invented by Joshua SK Bell (Chicago), Catherine Igartua (Chicago) and Joshua Drews (Downers Grove, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods are provided for performing quality control analysis. The method obtains, in electronic form, a batch dataset comprising, for each respective sample in a batch of samples, a corresponding plurality of sequence reads derived from the respective sample by targeted or whole transcriptome RNA sequencing and corresponding metadat...